e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine

A meta-epidemiological study on the reported treatment effect of pregabalin in neuropathic pain trials over time.

Emma T L Cheng; Mohammad Cheik-Hussein; Noelle Lin; Adriane M Lewin; James H McAuley; Ian A Harris · 2023 · PLoS ONE

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

The finding, in one line

However more recent studies have failed to replicate these results.

Abstract

Background Pregabalin is a drug used to treat neuropathic pain, and its use has increased substantially since 2007. Early trials found a strong treatment effect on pain for post-herpetic neuralgia and diabetic neuropathy. However more recent studies have failed to replicate these results. Methods This meta-epidemiological study aimed to assess change in the reported effectiveness of pregabalin in neuropathic pain trials over time, and if a change is present, determine any associated factors. Data sources We performed electronic searches for published trials in Medline, Embase and Cochrane Cent

Abstract by Emma T L Cheng; Mohammad Cheik-Hussein; Noelle Lin; Adriane M Lewin; James H McAuley; Ian A Harris, PLoS ONE (2023) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1371/journal.pone.0280593